Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · FRACTYL HEALTH, INC. (GUTS)

Fractyl Health adds Michael Wartell as independent director, board grows to ten

Neutral Impact 2 of 5 leadership

Fractyl Health's board increased its size from nine to ten and appointed Michael Wartell as an independent Class III director effective November 2, 2026. Wartell will receive $40,000 per month in cash compensation under a director agreement, with a minimum of three months guaranteed unless he resigns.

Key points

  • Michael Wartell appointed effective November 2, 2026; term expires at the 2027 annual meeting
  • Cash compensation of $40,000 per month, payable monthly in advance, with a three-month minimum unless he resigns
  • Additional $3,000 for each day Board commitments exceed four hours outside normal Board duties
  • Wartell has not been appointed to any Board committee and will not join the Non-Employee Director Compensation Policy

The filing

CompanyFRACTYL HEALTH, INC. (GUTS)
Form8-K, current report
Filed with the SECNov 6, 2026, 4:30 PM ET
Accession number0001193125-26-451917

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 7:05 AM ET, from this filing only.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.